KIMBERLY BACOLOR: Open Payments
NPI 1497532691 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 36 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $1,028 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $574 |
| Insmed, Inc. | 5 | $79 |
| Melinta Therapeutics, LLC | 2 | $45 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Kerecis Limited | 3 | $33 |
| Merck Sharp & Dohme LLC | 1 | $23 |
Products named: EMBLAVEO, DALVANCE, AVYCAZ, Arikayce, NUZYRA, Kerecis SurgiClose, TEFLARO, ZERBAXA.
Industry payments across NV — which companies pay providers there.
